{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:34:44Z","timestamp":1792002884017,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10096-020-04004-5","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T15:04:10Z","timestamp":1596812650000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Second- and third-generation commercial Neisseria gonorrhoeae screening assays and the ongoing issues of false-positive results and confirmatory testing"],"prefix":"10.1007","volume":"40","author":[{"given":"Todd M.","family":"Pryce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie J.","family":"Hiew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J.","family":"Haygarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Whiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"4004_CR1","doi-asserted-by":"publisher","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","volume":"10","author":"L Newman","year":"2015","unstructured":"Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N et al (2015) Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One 10:e0143304","journal-title":"PLoS One"},{"key":"4004_CR2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1128\/JCM.03223-12","volume":"51","author":"C Bromhead","year":"2013","unstructured":"Bromhead C, Miller A, Jones M, Whiley D (2013) Comparison of the cobas 4800 CT\/NG test with culture for detecting Neisseria gonorrhoeae in genital and nongenital specimens in a low-prevalence population in New Zealand. J Clin Microbiol 51:1505\u20131509","journal-title":"J Clin Microbiol"},{"key":"4004_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/sextrans-2014-051850","volume":"91","author":"N Field","year":"2015","unstructured":"Field N, Clifton S, Alexander S, Ison CA, Hughes G, Beddows S et al (2015) Confirmatory assays are essential when using molecular testing for Neisseria gonorrhoeae in low-prevalence settings: insights from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sex Transm Infect 91:338\u2013341","journal-title":"Sex Transm Infect"},{"key":"4004_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/sextrans-2013-051410","volume":"90","author":"MD Perry","year":"2014","unstructured":"Perry MD, Jones RN, Corden SA (2014) Is confirmatory testing of Roche cobas 4800 CT\/NG test Neisseria gonorrhoeae positive samples required? Comparison of the Roche cobas 4800 CT\/NG test with an opa\/pap duplex assay for the detection of N. gonorrhoeae. Sex Transm Infect 90:303\u2013308","journal-title":"Sex Transm Infect"},{"key":"4004_CR5","first-page":"358","volume":"29","author":"DW Smith","year":"2005","unstructured":"Smith DW, Tapsall JW, Lum G (2005) Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell Q Rep 29:358\u2013365","journal-title":"Commun Dis Intell Q Rep"},{"key":"4004_CR6","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1128\/JCM.01217-11","volume":"49","author":"SN Tabrizi","year":"2011","unstructured":"Tabrizi SN, Unemo M, Limnios AE, Hogan TR, Hjelmevoll SO, Garland SM et al (2011) Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. J Clin Microbiol 49:3610\u20133615","journal-title":"J Clin Microbiol"},{"key":"4004_CR7","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1128\/JCM.00485-13","volume":"51","author":"A Upton","year":"2013","unstructured":"Upton A, Bromhead C, Whiley DM (2013) Neisseria gonorrhoeae false-positive result obtained from a pharyngeal swab by using the Roche cobas 4800 CT\/NG assay in New Zealand in 2012. J Clin Microbiol 51:1609\u20131610","journal-title":"J Clin Microbiol"},{"key":"4004_CR8","first-page":"E42","volume":"39","author":"DM Whiley","year":"2015","unstructured":"Whiley DM, Lahra MM (2015) National Neisseria Network. Review of 2005 Public Health Laboratory Network Neisseria gonorrhoeae nucleic acid amplification tests guidelines. Commun Dis Intell Q Rep 39:E42\u2013E45","journal-title":"Commun Dis Intell Q Rep"},{"issue":"RR-02","key":"4004_CR9","first-page":"1","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","unstructured":"Centers for Disease Control and Prevention (2014) Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae-2014. MMWR Recomm Rep 63(RR-02):1\u201319","journal-title":"MMWR Recomm Rep"},{"key":"4004_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/OLQ.0b013e31817bdd7e","volume":"35","author":"J Schachter","year":"2008","unstructured":"Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD (2008) Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 35:637\u2013642","journal-title":"Sex Transm Dis"},{"key":"4004_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1128\/JCM.01976-14","volume":"53","author":"C Bromhead","year":"2015","unstructured":"Bromhead C, Liyanarachchy N, Mayes J, Upton A, Balm M (2015) Supplementary testing is not required in the cobas 4800 CT\/NG test for Neisseria gonorrhoeae weak-positive urogenital samples. J Clin Microbiol 53:327\u2013328","journal-title":"J Clin Microbiol"},{"key":"4004_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/sextrans-2014-051802","volume":"90","author":"JS Moore","year":"2014","unstructured":"Moore JS, Gaukrodger N, Bignardi G (2014) Neisseria gonorrhoeae confirmatory testing: helpful or a hindrance? Sex Transm Infect 90:595","journal-title":"Sex Transm Infect"},{"key":"4004_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.diagmicrobio.2007.12.007","volume":"61","author":"N Goire","year":"2008","unstructured":"Goire N, Nissen MD, LeCornec GM, Sloots TP, Whiley DM (2008) A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis 61:6\u201312","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4004_CR14","doi-asserted-by":"crossref","unstructured":"Ripa T, Nilsson P (2006) A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill 11(11):E061109.2","DOI":"10.2807\/esw.11.45.03076-en"},{"key":"4004_CR15","doi-asserted-by":"crossref","unstructured":"Trembizki E, Lahra M, Stevens K, Freeman K, Hogan T, Hogg G, Lawrence A, Limnios A, Pearson J, Smith H, Nissen M, Sloots T, Whiley D, On Behalf Of \u2018grand\u2019 Study Investigators (2014) A national quality assurance survey of Neisseria gonorrhoeae testing. J Med Microbiol 63(Pt 1):45\u201349","DOI":"10.1099\/jmm.0.065094-0"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-04004-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T23:43:07Z","timestamp":1628293387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-04004-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4004"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-04004-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"assertion":[{"value":"18 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TP: NilVH: NilEH: NilDW: reports research funding from SpeeDx Pty Ltd., and SpeedDx was not part of this study whatsoever.We confirm that Abbott, Roche or Cepheid had no role in the design of this study, the collection, analysis, interpretation of data, or the write-up of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable: according to the National Statement on Ethical Conduct in Human Research 2007 (Updated May 2015) by the National Health and Medical Research Council, Australian Research Council and Australian Vice-Chancellors\u2019 Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable (as above)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable (as above)","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}